We specialize in offering a wide range of differentiated generic Pharmaceutical and Nutraceutical products, including Pre-Formulation Intermediates (PFI) and Finished Formulations (FF), to customers worldwide. Our portfolio includes granules, pellets (sustained, modified, and extended-release), taste-masked powders, suspensions, tablets, capsules, and Oral Thin Films (OTF), developed using our patented Thinoral® technology.

We strive to provide our customers with an affordable, science-driven, and comprehensive range of pharmaceutical products targeting a broad spectrum of therapeutic segments, including Cardiovascular Diseases, Anti-infectives, Gastrointestinal Disorders, Respiratory Illnesses, Urology, Nervous System Disorders, Musculoskeletal Conditions, NSAID/Pain Management, and Hematology. Our products are meticulously formulated and rigorously tested to ensure the highest standards of quality and efficacy, thereby contributing to the overall well-being of the patients we serve.

At ZIM Laboratories FZE, we are dedicated to a holistic approach to healthcare, prioritizing the well-being of the end customer. We focus on delivering world-class, research-driven, and highly effective Nutraceutical products and healthcare supplements that address lifestyle diseases, nutritional deficiencies, and related health concerns. Our commitment lies in providing innovative healthcare solutions that empower our customers to lead healthier and more fulfilling lives.

1. ZIM Laboratories Middle East DMCC (Subsidiary of ZIM Lab FZE) :

Incorporated in September 2023 as a subsidiary of ZIM Laboratories FZE, Sharjah, UAE, for product registrations and marketing and distribution initiatives in MENA* and Africa regions.

2. ZIM Scientific Office LLP (Subsidiary of ZIM Lab FZE) :

Incorporated in November 2024 as a subsidiary of ZIM Laboratories FZE, Sharjah, UAE, to drive order distribution initiatives across the MENA* regions and *MENA: Middle East & North Africa